Quick Heal Technologies Q4 FY25: Revenue ₹65.1 Cr, PAT ₹3.3 Cr
Q4 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹65Cr
- −18.6% YoY
- −7.7% QoQ
- Net profit
- −₹3Cr
- Q4 FY24: ₹14 Cr
- Margin
- −13.02%
- −25.6 pp YoY
- −7.7 pp QoQ
Top 10 IT - Software companies on management guidance
See the sector's top 10 — free with your mobile number.
Quick Heal Technologies Ltd Q4 FY25 key numbers
- Revenue
- FY25 Revenue: ₹279.5 Cr, down from ₹291.8 Cr in FY24 (-4.2% YoY).
As stated in Quick Heal Technologies Ltd's Q4 FY25 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on Quick Heal Technologies Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. Q4 FY25 EBITDA: -₹8.5 Cr (down from ₹10.0 Cr in Q4 FY24) - Q4 FY25 EBITDA Margin: -13.0% (down from 12.6% in Q4 FY24) - Q4 FY25 Profit After Tax (PAT): -₹3.3 Cr (down from ₹14.0 Cr in Q4 FY24) - Q4 FY25 PAT Margin: -5.0% (down from 17.5% in Q4 FY24) Year-on-Year changes indicate a significant decline in profitability and margins compared to the same quarter previous year.
From Quick Heal Technologies Ltd's Q4 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. -18.6% YoY) (Page 31)
- FY25 Revenue: ₹279.5 Cr, down from ₹291.8 Cr in FY24 (-4.2% YoY) (Page 24, 31)
- Consumer Revenue FY25: ₹185.7 Cr, down 9.2% YoY (Page 25, 24)
2 more points from Quick Heal Technologies Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Order Book: INR 24+ Cr as on date (Page 20, Business Highlights)
- New Product Billing: FY25 > 3x FY24 (Page 20)
- Deferred Revenue: INR 12+ Cr (Page 20)
- First order for Seqrite Threat Intelligence received (Page 20)
Quick Heal Technologies Ltd — Quarterly revenue & net profit
Quick Heal Technologies Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 65 | 80 | -18.6% | 71 | -7.7% |
| Operating profit (EBITDA) | -8 | 10 | -184.5% | -4 | — |
| Operating margin | -13.02% | 12.55% | -25.6 pp | -5.34% | -7.7 pp |
| Profit before tax | -7 | 14 | -148.5% | -2 | — |
| Net profit (PAT) | -3 | 14 | -123.1% | 0 | -3054.5% |
| EPS (₹) | -0.60 | 2.62 | -122.9% | 0.02 | -3100% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Quick Heal Tech's management said in earlier quarters
Others in IT - Software this season
- ASM Technologies (Q4 FY25)
Q4 FY24: ₹445.92 million . Key concall takeaways from ASM Technologies Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Olatech Solution (Q4 FY25)
Current order book in hand: ₹35 crores (as of June 2025). Key concall takeaways from Olatech Solutions Ltd's Q4 FY25 earnings call — and how it ranks against…
- Birlasoft Ltd (Q4 FY25)
The company has a strong cash position with cash and cash equivalents growing 24% YoY to $259.5 million as of FY25 end. Key concall takeaways from Birlasoft…
- Wipro (Q4 FY25)
FY25 experienced a 2.3% decline in IT Services revenue (constant currency); Q4 saw a sequential decline of 0.8%. Key concall takeaways from Wipro Ltd's Q4 FY25…
Potential multibaggers · Q2 FY27
Potential multibaggers in IT - Software
on management's own guidance
- Strong growth2
- Strong growth1
- Fractal AnalyticsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Quick Heal Technologies Ltd Q4 FY25 results?
Q4 FY25 Revenue: ₹65.1 Cr, down from ₹80.0 Cr in Q4 FY24 (approx. Q4 FY25 EBITDA: -₹8.5 Cr (down from ₹10.0 Cr in Q4 FY24) - Q4 FY25 EBITDA Margin: -13.0% (down from 12.6% in Q4 FY24) - Q4 FY25 Profit After Tax (PAT): -₹3.3 Cr (down from ₹14.0 Cr in Q4 FY24) - Q4 FY25 PAT Margin: -5.0% (down from 17.5% in Q4 FY24) Year-on-Year changes indicate a significant decline in profitability and margins compared to the same quarter previous year.
What is Quick Heal Technologies Ltd share price analysis?
Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹827 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
